Conavi Medical Corp
(MENAFN- Baystreet) 09:18 AM EST - Conavi Medical Corp: Announced its participation in Transcatheter Cardiovascular Therapeutics 2026, taking place October 31–November 3, 2026, at the San Diego Convention Center in San Diego, California. This will be Conavi's first TCT conference since receiving U.S. Food and Drug Administration 510(k) clearance for its next-generation hybrid intravascular ultrasound and optical coherence tomography imaging system. Conavi Medical Corp
shares V are trading unchanged at $0.14.
Full Press Release:
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Comments
No comment